Letter regarding article by Lazar et al, "Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events".
Carvalho
George
G
Schricker
Thomas
T
D001786:Blood Glucose / Q000032:analysis*; D019090:Case Management / Q000592:standards; D002626:Chemistry, Pharmaceutical; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000097:blood / Q000150:complications / Q000601:surgery*; D048909:Diabetes Complications / Q000097:blood / Q000601:surgery*; D005947:Glucose / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D011188:Potassium / Q000008:administration & dosage / Q000627:therapeutic use*; D012107:Research Design
D001786:Blood Glucose; D007328:Insulin; C030396:glucose-insulin-potassium cardioplegic solution; D005947:Glucose; D011188:Potassium